Skip to content
Aero Interactive

Brand strategy for people and machines

Grannus Therapeutics: First-in-class Hsp90‌β-Selective Oncology Innovation

Grannus is pioneering a breakthrough generation of Hsp90 inhibitors that are highly selective for the β‑isoform. They deliver potent anti‑tumor efficacy, clean safety profiles, and strong tumor‑targeted biodistribution. Grannus is advancing toward clinical milestones with robust IP protection.

Grannus Therapeutics: First-in-class Hsp90‌β-Selective Oncology Innovation

Project scope

Scope

Aero designed Grannus Therapeutics' website and brand, built it in Webflow, and maintains it.

What we delivered

  • Web and brand design
  • A launch strategy session
  • A Webflow build
  • Ongoing maintenance, including team and board updates

From the journal

Field Notes

Start a project

Make your product agent-ready

We design the products, websites and design systems your customers use and their AI agents act on.

  • Agentic product design
  • Design systems AI agents can read
  • Booking for Q1 2027